查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496757

藥物發現市場：按藥物類型、技術、治療領域和最終用戶分類 - 2024-2030 年全球預測

Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年藥物發現市場規模為623.8億美元，2024年將達711.2億美元，預計2030年將達到1571.3億美元，複合年成長率為14.10%。

藥物發現是一個多方面且複雜的過程，涉及識別新化合物、闡明生物標的以及確定疾病的治療潛力。這個過程是開發新藥的基礎，需要生物學、化學、藥理學和醫學等各領域的科學家的合作。製藥和生物製藥行業研發（R＆D）支出的增加以及政府對新興市場發展的支持正在推動市場成長。此外，管理臨床前研究期間產生的大量資料的需求不斷成長也推動了市場的成長。藥物發現和市場開拓需要巨額資金，而在藥物發現中使用動物的嚴格規範阻礙了市場成長。藥物發現領域的技術進步和創新，以及擴大使用人工智慧雲來創建簡化和自動化的藥物發現方法，預計將使藥物發現有望顯著成長。

主要市場統計
基準年[2023] 623.8億美元
預測年份 [2024] 711.2億美元
預測年份 [2030] 1571.3億美元
複合年成長率（%） 14.10%

區域洞察

美洲擁有強大的藥物發現基礎設施，包括對研發的大量投資、大型製藥公司的存在以及完善的法規環境。醫療保健基礎設施投資的增加以及應對當地健康挑戰的醫療創新需求不斷成長，正在加速美洲對藥物發現解決方案的需求。在歐洲，先進的醫療保健系統、大量的政府和私人資金以及對國家間創新與合作的高度重視正在推動藥物發現的需求。在中東和非洲，由於醫療支出的增加和當地製藥業發展的努力，需求正在增加。由於人口眾多、經濟日益繁榮、醫療基礎設施改善、醫療意識不斷增強，以及政府支持生物技術和製藥行業的舉措不斷湧現，亞太地區正迅速成為藥物發現市場的主要參與者。

FPNV定位矩陣

FPNV定位矩陣對於評估藥物發現市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對藥物發現市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在藥物發現市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫藥及生技製藥產業研發費用增加
      • 管理臨床前研究期間產生的大量資料的需求日益增加
      • 政府對藥物發現平台開發的有利支持
    • 抑制因素
      • 藥物發現和開發需要大量資金
    • 機會
      • 藥物發現的技術進步與創新
      • 使用 AI 雲創建藥物發現的簡化自動化方法
    • 任務
      • 在藥物發現中使用動物的嚴格標準
  • 市場區隔分析
    • 藥物類型：對品牌藥和非專利藥小分子藥物的需求不斷增加
    • 技術：擴大生物分析儀器的使用和早期高通量篩檢
    • 治療領域：腫瘤治療藥物開發中對藥物發現的需求不斷增加
    • 最終用戶：製藥和生物技術公司更多地利用藥物發現來開發新的和改進的藥物
  • 市場趨勢分析
    • 優先考慮美洲的先進和創新藥物發現技術
    • 亞太地區藥物開發臨床試驗的增加和稅收優惠的可用性
    • 政府支持歐洲、中東和非洲地區藥物發現和開發的資金和舉措
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章按藥物類型分類的藥物發現市場

  • 生物製藥
  • 小分子藥物

第7章藥物發現市場：依技術分類

  • 生物分析設備
  • 生物晶片
  • 生物資訊學
  • 組合化學
  • 高通量篩檢
  • 奈米科技
  • 藥物基因組學

第8章按治療領域分類的藥物發現市場

  • 循環系統疾病
  • 消化系統疾病
  • 感染疾病和免疫系統疾病
  • 神經病學
  • 腫瘤學

第9章藥物發現市場：依最終使用者分類

  • 學術研究機構
  • 合約調查機構
  • 製藥公司

第10章美洲藥物發現市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太藥物發現市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的藥物發現市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Evommune 和 Accutar Biotechnology 宣布開展人工智慧合作
    • IGC Pharma 簽署協議，將人工智慧解決方案引入藥物發現
    • 筑波大學與Astellas來製藥結成策略聯盟
    • Mestastop 籌集了 50 萬美元，以進一步推進癌症治療的藥物發現
    • Sosei 與 Farm Enable 合作開發新型神經藥物
    • 諾和諾德和 Evotech 推出轉換加速器
    • Genesis 籌集 2 億美元用於人工智慧研究
    • Revvity 推出首個科學 SaaS 平台以加速藥物和材料開發
    • BenchSci 籌集了 9,500 萬美元的 D 輪資金籌措，利用突破性的人工智慧平台 ASCEND 實現大規模藥物發現創新
    • Google Cloud 宣布推出人工智慧驅動的解決方案，以安全地加速藥物發現和精準醫療
    • Recursion計劃斥資8,750萬美元收購以強化人工智慧藥物發現
    • Eurofins Discovery 收購 CALIXAR，擴大綜合藥物發現能力和專業知識
    • PerkinElmer 推出多模式盤式分析儀以幫助加速藥物發現
    • LabGenius 獲得政府創新津貼，以擴展機器學習驅動的藥物發現平台 EVA
    • Insight 宣布 FDA核准Pemazyre (Pemigatinib) 作為 FGFR1 重排的髓樣淋巴腫瘤 (MLN) 的標靶治療

第14章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-434CCDA0516F

[189 Pages Report] The Drug Discovery Market size was estimated at USD 62.38 billion in 2023 and expected to reach USD 71.12 billion in 2024, at a CAGR 14.10% to reach USD 157.13 billion by 2030.

Drug discovery is a multifaceted and intricate process that encompasses the identification of novel compounds, the elucidation of their biological targets, and the determination of their therapeutic potential for the treatment of diseases. This process is fundamental to developing new medicines and involves a collaborative effort among scientists from various disciplines, including biology, chemistry, pharmacology, and medicine. Rising research and development (R&D) expenditure in the pharmaceutical and biopharmaceutical industry and favorable government support for developing drug discovery platforms are propelling the market growth. In addition, the increasing need to manage large amounts of data generated during preclinical studies is fueling market growth. The necessity of extensive capital for drug discovery and development and stringent norms for animal usage in drug discovery are hampering market growth. Technological advancements and innovations in drug discovery and the growing use of AI cloud to create a streamlined and automated approach to drug discovery are expected to be poised for significant growth in drug discovery.

KEY MARKET STATISTICS
Base Year [2023] USD 62.38 billion
Estimated Year [2024] USD 71.12 billion
Forecast Year [2030] USD 157.13 billion
CAGR (%) 14.10%

Regional Insights

Americas represents a robust drug discovery infrastructure with significant investments in R&D, a strong presence of pharmaceutical giants, and a conducive regulatory environment. Increasing investment in healthcare infrastructure and growing need for medical innovation to address local health concerns are accelerating the need for drug discovery solutions in the Americas. In Europe, the need for drug discovery is fueled by advanced healthcare systems, substantial government and private funding, and a strong focus on innovation and collaboration across countries. The Middle East and Africa exhibit growing need, with increased healthcare spending and initiatives to foster local pharmaceutical industries. The Asia-Pacific region is rapidly emerging as a significant player in the drug discovery market due to its large population, increasing economic prosperity, improvements in healthcare infrastructure, rising healthcare awareness, and government initiatives to support the biotechnology and pharmaceutical sectors.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Drug Discovery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising R&D Expenditure in the Pharmaceutical & Biopharmaceutical industry
      • Increasing Need to Manage Large Data Generated During Preclinical Studies
      • Favorable Government Support For the Development of Drug Discovery Platforms
    • Market Restraints
      • Requirement of Extensive Capital for Drug Discovery and Development
    • Market Opportunities
      • Technological Advancements and Innovations in Drug Discovery
      • Use of AI Cloud to Create a Streamlined and Automated Approach in Drug Discovery
    • Market Challenges
      • Stringent Norms for the Animal Usage in Drug Discovery
  • Market Segmentation Analysis
    • Drug Type: Growing need for small molecule drugs with branded and generic products
    • Technology: Growing utilization of bioanalytical instruments and high throughput screening for initial drug discovery phases
    • Therapeutic Area: Increasing need of drug discovery for the development of oncology drugs
    • End User: Growing drug discovery use across pharmaceutical and biotechnology companies for developing new and improved drugs
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Drug Discovery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Drug Discovery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration

Evommune, Inc. collaborated with Accutar Biotechnology, Inc., specializing in AI-driven drug discovery, to co-develop therapies for debilitating dermatological conditions. This strategic collaboration intends to leverage Accutar's AI platform to accelerate Evommune's drug discovery and development process, circumventing traditional bottlenecks and paving the way for innovative treatments. [Published On: 2023-11-28]

IGC Pharma signs agreement to adopt AI solutions into drug discovery

IGC Pharma signed an agreement with the University of Los Andes in Colombia to develop and adopt generative artificial intelligence (AI) solutions to detect, develop, and trial new drugs. Under the agreement, the company leverages generative AI to streamline the efficiency of its clinical trials, improve early Alzheimer's disease detection approaches, and enhance drug interaction assessments. [Published On: 2023-11-22]

University of Tsukuba and Astellas Confirm a Strategic Partnership

Astellas Pharma Inc. partnered with the University of Tsukuba to integrate "targeted protein degradation" technology into their portfolio, a pivotal step that enhances their research capabilities. The implementation of this innovative approach aims to transcend the limitations of traditional drug development by strategically degrading disease-causing proteins. [Published On: 2023-11-16]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Drug Discovery Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alacrita Holdings Limited, Astex Pharmaceuticals by Otsuka Pharmaceutical Co., Ltd., Astrazeneca PLC, Atomwise, Inc., BenevolentAI, Bio-Rad Laboratories, Inc., BioSymetrics Inc., Charles River Laboratories International, Inc., Chembridge Corporation, Cloud Pharmaceuticals, Inc., Dalriada Drug Discovery, Deciphera Pharmaceuticals, Inc., Evotec SE, F. Hoffmann-La Roche Ltd., GENFIT SA, Incyte Corporation, International Business Machines Corporation, Intra-Cellular Therapies Inc., Merck KGaA, Microsoft Corporation, NVIDIA Corporation, PerkinElmer, Inc., Pharmacelera SL, Piramal Group, Recursion Pharmaceuticals, Inc., Schrodinger, Inc., Shimadzu Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Type
    • Biologic Drugs
    • Small Molecule Drugs
  • Technology
    • Bioanalytical Instruments
    • Biochips
    • Bioinformatics
    • Combinatorial Chemistry
    • High Throughput Screening
    • Nanotechnology
    • Pharmacogenomics
  • Therapeutic Area
    • Cardiovascular Disease
    • Digestive System Diseases
    • Infectious & Immune system Diseases
    • Neurology
    • Oncology
  • End User
    • Academics & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Georgia
        • Illinois
        • Indiana
        • Michigan
        • New York
        • North Carolina
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising R&D Expenditure in the Pharmaceutical & Biopharmaceutical industry
      • 5.1.1.2. Increasing Need to Manage Large Data Generated During Preclinical Studies
      • 5.1.1.3. Favorable Government Support For the Development of Drug Discovery Platforms
    • 5.1.2. Restraints
      • 5.1.2.1. Requirement of Extensive Capital for Drug Discovery and Development
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements and Innovations in Drug Discovery
      • 5.1.3.2. Use of AI Cloud to Create a Streamlined and Automated Approach in Drug Discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent Norms for the Animal Usage in Drug Discovery
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Type: Growing need for small molecule drugs with branded and generic products
    • 5.2.2. Technology: Growing utilization of bioanalytical instruments and high throughput screening for initial drug discovery phases
    • 5.2.3. Therapeutic Area: Increasing need of drug discovery for the development of oncology drugs
    • 5.2.4. End User: Growing drug discovery use across pharmaceutical and biotechnology companies for developing new and improved drugs
  • 5.3. Market Trend Analysis
    • 5.3.1. Preference for advanced and innovative drug discovery technologies in the Americas
    • 5.3.2. Proliferating number of clinical trials and availability of tax-incentives for drug development across the Asia-Pacific
    • 5.3.3. Supportive government funding and initiatives for drug discovery and development in the EMEA region
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Drug Discovery Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Biologic Drugs
  • 6.3. Small Molecule Drugs

7. Drug Discovery Market, by Technology

  • 7.1. Introduction
  • 7.2. Bioanalytical Instruments
  • 7.3. Biochips
  • 7.4. Bioinformatics
  • 7.5. Combinatorial Chemistry
  • 7.6. High Throughput Screening
  • 7.7. Nanotechnology
  • 7.8. Pharmacogenomics

8. Drug Discovery Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Disease
  • 8.3. Digestive System Diseases
  • 8.4. Infectious & Immune system Diseases
  • 8.5. Neurology
  • 8.6. Oncology

9. Drug Discovery Market, by End User

  • 9.1. Introduction
  • 9.2. Academics & Research Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical Companies

10. Americas Drug Discovery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Discovery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration
    • 13.3.2. IGC Pharma signs agreement to adopt AI solutions into drug discovery
    • 13.3.3. University of Tsukuba and Astellas Confirm a Strategic Partnership
    • 13.3.4. Mestastop Raises USD 500k To Further Its Cancer Drug Discovery
    • 13.3.5. Sosei and PharmEnable collaborate on another neurological drug
    • 13.3.6. Novo Nordisk and Evotec launch translational drug discovery accelerator
    • 13.3.7. Genesis Raises USD 200 Million For AI Drug Discovery Research
    • 13.3.8. Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development
    • 13.3.9. BenchSci Raises USD 95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND
    • 13.3.10. Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
    • 13.3.11. Recursion Plans USD 87.5m Acquisitions To Shore Up AI Drug Discovery
    • 13.3.12. Eurofins Discovery Acquires CALIXAR, Expanding Integrated Drug Discovery Capabilities and Expertise
    • 13.3.13. PerkinElmer Unveils Multimode Plate Reader To Expedite Drug Discovery
    • 13.3.14. LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA
    • 13.3.15. Incyte Announces FDA Approval Of Pemazyre (Pemigatinib) As Targeted Treatment For Myeloid/Lymphoid Neoplasms (MLNs) With FGFR1 Rearrangement

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DRUG DISCOVERY MARKET DYNAMICS
  • FIGURE 7. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DISCOVERY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DISCOVERY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOCHIPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOCHIPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS & IMMUNE SYSTEM DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS & IMMUNE SYSTEM DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 116. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 123. CHINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 124. CHINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 125. CHINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 126. CHINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 131. INDIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 132. INDIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 133. INDIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. INDIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 139. INDONESIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 140. INDONESIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 141. INDONESIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. INDONESIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 147. JAPAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 148. JAPAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 149. JAPAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 150. JAPAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 155. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 156. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 157. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 158. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 164. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 166. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 172. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 173. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 180. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 187. TAIWAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 188. TAIWAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 189. TAIWAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 190. TAIWAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. THAILAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 196. THAILAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 197. THAILAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. THAILAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 203. VIETNAM DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 204. VIETNAM DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 205. VIETNAM DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. VIETNAM DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. DENMARK DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 222. DENMARK DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 223. DENMARK DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 224. DENMARK DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 229. EGYPT DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 230. EGYPT DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 231. EGYPT DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. EGYPT DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. FINLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 238. FINLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 239. FINLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 240. FINLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 245. FRANCE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 246. FRANCE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 247. FRANCE DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 248. FRANCE DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 253. GERMANY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 254. GERMANY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 255. GERMANY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. GERMANY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. ISRAEL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 262. ISRAEL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 263. ISRAEL DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 264. ISRAEL DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 269. ITALY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 270. ITALY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 271. ITALY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 272. ITALY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 278. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 279. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 280. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 285. NIGERIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 286. NIGERIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 287. NIGERIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 288. NIGERIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. NORWAY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 294. NORWAY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 295. NORWAY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 296. NORWAY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 301. POLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 302. POLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 303. POLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 304. POLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 309. QATAR DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 310. QATAR DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 311. QATAR DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 312. QATAR DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. RUSSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 316. RUSSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 317. RUSSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 318. RUSSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 319. RUSSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 320. RUSSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 324. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 325. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 326. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 327. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 328. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 335. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 336. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 339. SPAIN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 340. SPAIN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 341. SPAIN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 342. SPAIN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 343. SPAIN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 344. SPAIN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. SWEDEN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 348. SWEDEN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 349. SWEDEN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 350. SWEDEN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 351. SWEDEN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 352. SWEDEN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 356. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 357. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 358. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 359. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 360. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 361. TURKEY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 362. TURKEY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 363. TURKEY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 364. TURKEY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 365. TURKEY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 366. TURKEY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 367. TURKEY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 368. TURKEY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 369. UNIT